Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 8/20 | 0.48 |
| ▸ | ABCC9 | O60706 | 1/20 | 0.41 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5868249 | 1.00 | KCNA5 (0.48) | KCNA5ABCC9ABCB1 | |
| SCHEMBL5868254 | 1.00 | KCNA5 (0.48) | KCNA5ABCC9ABCB1 | |
| SCHEMBL5868217 | 0.90 | KCNA5 (0.57) | KCNA5ABCB1 | |
| SCHEMBL5868219 | 0.90 | KCNA5 (0.57) | KCNA5ABCB1 | |
| SCHEMBL6273955 | 0.90 | KCNA5 (0.57) | KCNA5ABCB1 | |
| SCHEMBL2878003 | 0.82 | ABCB1 (0.40) | KCNA5ABCC9ABCB1 | |
| SCHEMBL2878005 | 0.82 | ABCB1 (0.40) | KCNA5ABCC9ABCB1 | |
| SCHEMBL27408232 | 0.82 | ABCC9 (0.61) | ABCC9 | |
| SCHEMBL6281202 | 0.80 | ABCB1 (0.64) | ABCC9ABCB1 | |
| SCHEMBL5868271 | 0.80 | ABCB1 (0.64) | ABCC9ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1401823-B1 | SUBSTITUTED BENZOPYRAN DERIVATIVES AGAINST ARRHYTHMIA | NISSAN CHEMICAL IND LTD (JP) | 2005-10-05 | — | — | EP | disclosed |
| EP-1401823-A1 | SUBSTITUTED BENZOPYRAN DERIVATIVES AGAINST ARRHYTHMIA | Nissan Chemical Industries, Ltd. (JP) | 2004-03-31 | — | — | EP | disclosed |
| WO-2003000675-A1 | SUBSTITUTED BENZOPYRAN DERIVATIVES AGAINST ARRHYTHMIA | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2003-01-03 | — | — | WO | disclosed |